Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Cancer Prev Res (Phila). 2012 Oct 19;5(12):1375–1380. doi: 10.1158/1940-6207.CAPR-12-0175

Table 2.

The association between pathologic characteristics of benign breast biopsies and subsequent breast cancer risk in African American women in Detroit, MI.

Breast Cancer Status Relative Riska
Negative Positive (95% C.I.) p value
Apocrine Metaplasia
 No 927 38 1.0 (Ref)
 Yes 422 17 0.93 (0.52-1.67) 0.80
Ductal Hyperplasia
 None 928 36 1.0 (Ref)
 Yes 415 19 1.14 (0.64-2.01) 0.66
Lobular Hyperplasia
 No 1330 54 1.0 (Ref)
 Yes 21 1 1.08 (0.14-8.21) 0.94
Cyst
 No 809 28 1.0 (Ref)
 Yes 540 27 1.41 (0.82-2.42) 0.21
Duct Ectasia
 No 1294 52 1.0 (Ref)
 Yes 57 3 1.33 (0.40-4.41) 0.64
Fibrosis
 No 505 21 1.0 (Ref)
 Yes 749 31 0.97 (0.55-1.71) 0.91
Intra-Ductal Papilloma
 None 1220 48 1.0 (Ref)
 1 or more 130 7 1.26 (0.55-2.84) 0.59
Sclerosing adenosis
 No 1266 48 1.0 (Ref)
 Yes 84 7 2.20 (0.96-5.01) 0.06
Columnar alteration
 No 1127 40 1.0 (Ref)
 Yes 222 15 1.84 (0.99-3.39) 0.05
Atrophy
 None 237 11 1.0 (Ref)
 Partial 700 27 0.75 (0.37-1.55) 0.44
 Complete 218 12 0.84 (0.34-2.07) 0.71
Overall Impression
 Non-Proliferative Disease 912 33 1.0 (Ref)
 Proliferative Disease without Atypia 388 17 1.16 (0.64-2.12) 0.62
 Proliferative Disease with Atypia 39 5 3.29 (1.21-8.93) 0.02
a

adjusted for age and year at biopsy